<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1">
<style type="text/css" style="display:none;"> P {margin-top:0;margin-bottom:0;} </style>
</head>
<body dir="ltr">
<div class="elementToProof" style="font-family: Calibri, Helvetica, sans-serif; font-size: 12pt; color: rgb(0, 0, 0);">
<br>
</div>
<div align="center">
<table style="width: 6.25in; box-sizing: border-box; border-collapse: collapse; border-spacing: 0px;">
<tbody>
<tr>
<td style="padding: 0in;">
<p style="margin-right: 0in; margin-left: 0in; font-family: "Times New Roman", serif; font-size: 12pt;">
<span style="font-family: Arial, sans-serif; font-size: 13.5pt; color: black;"><img alt="Dissertation Defense Announcement at the Cullen College of Engineering" id="x__x0000_i1025" width="598" height="170" style="width: 6.2395in; height: 1.7812in; margin-top: 0px; margin-bottom: 0px;" data-outlook-trace="F:1|T:1" src="cid:DDh9QHypV1kWN5MC3lKG"></span></p>
<div align="center">
<table style="background-color: white; box-sizing: border-box; border-collapse: collapse; border-spacing: 0px;">
<tbody>
<tr>
<td style="padding: 30pt 15pt 7.5pt;">
<p align="center" style="line-height: 21pt; margin-right: 0in; margin-left: 0in; font-family: "Times New Roman", serif; font-size: 12pt;">
<span style="font-size: 18pt; color: rgb(200, 16, 46);"><b>Regulation of High Blood Pressure using Somatic Neuromodulation</b></span></p>
<p align="center" style="line-height: 16.5pt; margin-right: 0in; margin-left: 0in; font-family: "Times New Roman", serif; font-size: 12pt;">
<b>USING MINIATURIZED WIRELESS NEURAL ELECTRODE</b></p>
<p align="center" style="line-height: 15pt; margin-right: 0in; margin-left: 0in; font-family: "Times New Roman", serif; font-size: 12pt;">
<span style="font-size: 13.5pt;"><b>Kevin Isae Romero</b></span></p>
<p align="center" style="line-height: 16.5pt; margin-right: 0in; margin-left: 0in; font-family: "Times New Roman", serif; font-size: 12pt;">
<span style="font-family: Arial, sans-serif; font-size: 10.5pt;">June 27<sup>th</sup> 2024; 11:00 AM - 12:30 AM (CST)</span></p>
<p align="center" style="line-height: 16.5pt; margin-right: 0in; margin-bottom: 3.75pt; margin-left: 0in; font-family: "Times New Roman", serif; font-size: 12pt;">
<span style="font-family: Arial, sans-serif; font-size: 10.5pt;"><b>Committee Chair:</b><br>
Metin Akay, Ph.D.</span></p>
<p align="center" style="line-height: 16.5pt; margin-right: 0in; margin-bottom: 15pt; margin-left: 0in; font-family: "Times New Roman", serif; font-size: 12pt;">
<span style="font-family: Arial, sans-serif; font-size: 10.5pt;"><b>Committee Members:</b></span></p>
<p style="margin: 0in 0in 0.0001pt; font-family: "Times New Roman", serif; font-size: 12pt;">
<span style="font-family: Arial, sans-serif; font-size: 10.5pt; color: black; background-color: white;">Scott Smith, Ph.D, | Yasemin Akay, Ph.D | Yungchen Du, Ph.D | Tianfu Wu, Ph.D </span></p>
</td>
</tr>
<tr>
<td style="padding: 0in 15pt 15pt;">
<p style="line-height: 16.5pt; margin-right: 0in; margin-bottom: 11.25pt; margin-left: 0in; font-family: "Times New Roman", serif; font-size: 12pt;">
<span style="font-family: Arial, sans-serif; color: rgb(200, 16, 46);"><b>Abstract</b></span></p>
<p style="margin: 0in 0in 0.0001pt; font-family: "Times New Roman", serif; font-size: 12pt;">
<span style="font-family: Arial, sans-serif; font-size: 10.5pt;">Hypertension is a main cause of death in the US with more than 103 million adults affected. While pharmacological treatments are effective, approximately 20-30% of hypertensive subjects do not
respond to these pharmalogical treatments also known as drug-resistant hypertension (DRH). Drug resistant hypertension is known to be a risk factor for cardiovascular events, including stroke, myocardial infarction, heart failure, and cardiovascular mortality,
as well as adverse renal events, including chronic kidney disease and end-stage kidney disease. This thesis aims to look at an alternative treatment for drug resistant hypertension through the use of neuromodulation of the common peroneal nerve to elicit a
depressor response in Spontaneously Hypertensive rats (SHR). Firstly, an acute study was performed on both SHR rats and normotensive rats (WKY) to optimize the stimulation parameters for neuromodulation treatment. The optimized parameters, 1 mA amplitude,
1 ms cathodic monophasic pulse, at 2 Hz were deemed to produce the best depressor response without causing damage to the peroneal nerve. After finding the optimal parameters for stimulation we performed a sub-chronic experiment in which animals implanted with
a novel wireless miniature electrode( w-µCE) and blood pressure (BP) telemetry systems underwent daily peroneal nerve stimulation at threshold for 8 minutes for five weeks. This reduced systolic blood pressure ( SBP) in WKY animals by -7 mmHg, and in SHR
animals by -20 mmHg during treatment (p<0.01). Ambulatory SBP measured daily recorded approximately twenty-four hours after the cPNS treatment, showed a significant reduction from the first (176.6 ± 24.1 mm Hg; n=5) to the last week of treatment (165.7± 42.7
mm Hg; n=4), a -9 mm Hg reduction (p<0.01). Evaluation of heart rate during the treatment showed no significant difference caused by the daily 8-minute cPNS. Electrical stimulation of the common peroneal nerve induced a reduction in SBP that is comparable
to that reportedly achieved pharmacologically by ACE inhibitor Ramipril, or by renal denervation procedures. Lastly histological analysis of the heart and aorta in which we analyzed heart wall thickness, aorta thickness, and fibrosis in the heart showed no
significant differences in the treatment group versus normotensive rats, highlighting that a longer treatment period might be needed to see significant changes in these anatomical structures. These results support the notion that neuromodulation of the common
peroneal nerve can serve as an alternative treatment for drug resistant hypertension.</span></p>
<p style="line-height: 16.5pt; margin-right: 0in; margin-bottom: 11.25pt; margin-left: 0in; font-family: "Times New Roman", serif; font-size: 12pt;">
<span><img alt="Engineered For What's Next" id="x__x0000_i1026" width="598" height="81" style="width: 6.2395in; height: 0.8541in; margin-top: 0px; margin-bottom: 0px;" data-outlook-trace="F:1|T:1" src="cid:OLxd3E0J9SpUTnbn6Ph6"></span></p>
</td>
</tr>
</tbody>
</table>
</div>
</td>
</tr>
</tbody>
</table>
</div>
<p style="margin: 0in 0in 0.0001pt; font-family: "Times New Roman", serif; font-size: 12pt;">
<span style="font-family: Calibri, sans-serif; font-size: 11pt; color: rgb(31, 73, 125);"> </span></p>
<p class="elementToProof" style="margin: 0in 0in 0.0001pt; font-family: "Times New Roman", serif; font-size: 12pt;">
<span style="font-family: Calibri, sans-serif; font-size: 11pt; color: rgb(31, 73, 125);"><br>
</span></p>
<div id="x_yahoo_quoted_9967183233">
<div id="x_yiv9076804314">
<div align="center"></div>
<div id="x_yiv9076804314yahoo_quoted_8406303310">
<div id="x_yiv9076804314">
<div id="x_yiv9076804314yahoo_quoted_9233043829">
<div id="x_yiv9076804314">
<div id="x_yiv9076804314ydpb442bae8yahoo_quoted_8578282382">
<div id="x_yiv9076804314ydpb442bae8yiv6992363308">
<div id="x_yiv9076804314ydpb442bae8yiv6992363308yahoo_quoted_6005667728">
<div id="x_yiv9076804314ydpb442bae8yiv6992363308"></div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</body>
</html>